… 400 points on Monday. Shares of Pagaya Technologies Ltd ( … .947 million. Pagaya Technologies shares jumped 17.4% to $28 … Biosciences Inc (NASDAQ:COGT) shares jumped 133.3% to $34 … MRD test in breast cancer. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) surged …

… for the guidance period. About Ironwood Pharmaceuticals Ironwood Pharmaceuticals (Nasdaq: IRWD) is a …   Weighted average number of common shares used to calculate net income …   Weighted average number of common shares used to calculate net income …

… for the guidance period. About Ironwood Pharmaceuticals Ironwood Pharmaceuticals (Nasdaq: IRWD) is a … )   Weighted average number of common shares used to calculate net income … )   Weighted average number of common shares used to calculate net income …

… . Gainers BrilliA Inc BRIA shares gained 150.4% to $ … across 22.5 million outstanding shares. The dividend carries a … -market trading. Solidion Technology shares jumped 114% on Wednesday after … R&D 100 Award. Ironwood Pharmaceuticals, Inc. IRWD declined 17. …

… for the guidance period. About Ironwood Pharmaceuticals Ironwood Pharmaceuticals (Nasdaq: IRWD) is a … ® are registered trademarks of Ironwood Pharmaceuticals, Inc. Any other trademarks … Weighted average number of common shares used to calculate net loss …

… the call has completed. About Ironwood Pharmaceuticals Ironwood Pharmaceuticals (Nasdaq: IRWD) is a …       Weighted average number of common shares used to calculate net income …       Weighted average number of common shares used to calculate net income …

Investing.com -- Shares of Ironwood Pharmaceuticals (NASDAQ:IRWD) soared by as … and market share. Investors in Ironwood Pharmaceuticals appear to be reacting to … Zealand Pharma's response, Ironwood Pharmaceuticals will likely continue to be …

… the call has completed. About Ironwood Pharmaceuticals Ironwood Pharmaceuticals (Nasdaq: IRWD), an S… )   Weighted average number of common shares used to calculate net income … )   Weighted average number of common shares used to calculate net income …

… the announcement. Analysts expect Ironwood Pharmaceuticals to report an earnings … 2.0% Ironwood Pharmaceuticals Share Price Analysis Shares of Ironwood Pharmaceuticals were trading … all earnings releases for Ironwood Pharmaceuticals visit their earnings …

Ironwood Pharmaceuticals is working with Goldman Sachs to evaluate “strategic alternatives” after a major regulatory setback derailed its plans to bring its lead drug candidate apraglutide to market. The move follows a 32% drop in Ironwood’s share price on …